DOI: 10.26686/wgtn.21937850
|View full text |Cite
|
Sign up to set email alerts
|

BCL6 is a context-dependent mediator of the glioblastoma therapy response

Abstract: <p>Glioblastoma is a rapidly fatal brain cancer with no cure. The resistance of glioblastoma tumours to available therapies means that more effective treatments are desperately needed. Previous research showed that the transcriptional repressor protein BCL6 is upregulated by chemo- and radiotherapy in glioblastoma and that inhibition of BCL6 enhances the effectiveness of these therapies. Therefore, BCL6 is a promising target to improve the efficacy of available treatments for glioblastoma. BCL6 is known … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Publication Types

Select...

Relationship

0
0

Authors

Journals

citations
Cited by 0 publications
references
References 549 publications
(1,388 reference statements)
0
0
0
Order By: Relevance

No citations

Set email alert for when this publication receives citations?